Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Financings in Brief: Diametrics Medical

This article was originally published in The Gray Sheet

Executive Summary

Diametrics Medical: Blood chemistry testing system manufacturer nets $29.3 mil. in a public offering of 3 mil. shares of its common stock for $10.50 per share. The St. Paul, Minnesota-based firm filed a registration statement for the offering in July ("The Gray Sheet" July 17, p. 31). The funds are tabbed for expanding sales and marketing, boosting manufacturing facilities, research and development of new blood analysis tests for the firm's IRMA system, as well as "general corporate purposes." UBS Securities, Vector Securities International, and Dain Bosworth have 30 days to exercise their 450,000 share over-allotment option, Diametrics says...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004477

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel